Home > Maligne hematologie > Lymfoïde ziekten > Non-Hodgkin lymfomen (NHL) > Mantelcellymfoom (MCL) > Hovon 119

Hovon 119

Efficacy of alternating immunochemotherapy consisting of RCHOP + R-HAD versus R-CHOP alone, followed by maintenance therapy consisting of additional lenalidomide with rituximab versus rituximab alone for older patients with mantle cell lymphoma

Deze print is 24 uur geldig na het aanmaken. Aangemaakt op: 26-4-2024, 1:16